Ear Care in France
In September 2012, Otipax, a common ear care product in France, was fully delisted from the official reimbursement list (listed at a 15% reimbursement rate until August 2012). This clearly confirms the ongoing impetus of the French authorities to continue de-reimbursement for benign ear care products, despite the arrival of the newly elected socialist government in May 2012, and in spite of political communication over a possible halt on the de-reimbursement spree. This was a de-reimbursement...
Euromonitor International's Ear Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Euromonitor International's Ear Care in France report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2008-2012, allowing you to identify the sectors driving growth. Forecasts to 2017 illustrate how the market is set to change.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
- Get a detailed picture of the Ear Care market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.
Headlines
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Ear Care: Value 2007-2012
Table 2 Sales of Ear Care: % Value Growth 2007-2012
Table 3 Ear Care Company Shares by Value 2008-2012
Table 4 Ear Care Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Ear Care: Value 2012-2017
Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
De-reimbursement Keeps Growing in France
France Welcomes the Approved List of Health and Nutrition Claims
Ameli Pushes for More Generics
Growing Competition Between Pharmacists and Other Distribution Channels
Moderate Growth Is Expected in the Forecast Period
Key Trends and Developments
the French Government Continues Its De-reimbursement Policy Because of Mounting Economic Problems in the Country
EU Adopts Vitamins and Dietary Supplements Approved List of Health and Nutrition Claims: Roadmap for Harmonisation in France
French Bodies Push for More Generic Drugs
Chemists/pharmacies Is Still the Most Frequented Channel for Consumer Health, But Faces Growing Competition
A Lethargic Socio-culture Impedes the Development of Self-medication
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Advertising
Vitamins and Dietary Supplements Registration and Classification
Distribution Channels
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2011-2012
Definitions
Sources
Summary 2 Research Sources
Trends
Switches
Competitive Landscape
Prospects
Category Data
Table 1 Sales of Ear Care: Value 2007-2012
Table 2 Sales of Ear Care: % Value Growth 2007-2012
Table 3 Ear Care Company Shares by Value 2008-2012
Table 4 Ear Care Brand Shares by Value 2009-2012
Table 5 Forecast Sales of Ear Care: Value 2012-2017
Table 6 Forecast Sales of Ear Care: % Value Growth 2012-2017
Executive Summary
De-reimbursement Keeps Growing in France
France Welcomes the Approved List of Health and Nutrition Claims
Ameli Pushes for More Generics
Growing Competition Between Pharmacists and Other Distribution Channels
Moderate Growth Is Expected in the Forecast Period
Key Trends and Developments
the French Government Continues Its De-reimbursement Policy Because of Mounting Economic Problems in the Country
EU Adopts Vitamins and Dietary Supplements Approved List of Health and Nutrition Claims: Roadmap for Harmonisation in France
French Bodies Push for More Generic Drugs
Chemists/pharmacies Is Still the Most Frequented Channel for Consumer Health, But Faces Growing Competition
A Lethargic Socio-culture Impedes the Development of Self-medication
Market Indicators
Table 7 Consumer Expenditure on Health Goods and Medical Services 2007-2012
Table 8 Life Expectancy at Birth 2007-2012
Market Data
Table 9 Sales of Consumer Health by Category: Value 2007-2012
Table 10 Sales of Consumer Health by Category: % Value Growth 2007-2012
Table 11 Consumer Health Company Shares 2008-2012
Table 12 Consumer Health Brand Shares 2009-2012
Table 13 Sales of Consumer Health by Distribution Format: % Analysis 2007-2012
Table 14 Sales of Consumer Health by Category and Distribution Format: % Analysis 2012
Table 15 Forecast Sales of Consumer Health by Category: Value 2012-2017
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2012-2017
Appendix
OTC Registration and Classification
Advertising
Vitamins and Dietary Supplements Registration and Classification
Distribution Channels
Self-medication/self-care and Preventative Medicine
Switches
Summary 1 OTC: Switches 2011-2012
Definitions
Sources
Summary 2 Research Sources
